Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • danwiththeplan
    Member
    • Sep 2011
    • 72

    QIIME constraints and time to run for 16S Illumina

    Hi, I am looking to help analyse a dataset that consists of a number of 16S (V3-V4) amplicons sequenced on a MiSeq (in triplicate) from a number of data points, with a view to getting the relative abundances of OTUs in the samples.
    I was wondering a few things:
    1) Are there any memory and / or processor-speed constraints when running QIIME, i.e. can you run every step in the pipeline on a reasonably good desktop (i7) with reasonable memory (8GB) in a reasonable time, or do you need to start using clusters or high-memory computers?
    2)Any estimates on how long (for example) it would take to run a simple comparison between sample A and sample B (triplicated) to get relative abundances of OTUs and the appropriate pretty graphs?
    3) Are there any common stumbling blocks that people tend to encounter, either in the setup or the running? I have already set it up natively on Ubuntu 12.04 LTS with only a few problems, and I understand the VDIs are good too.

    Any help or feedback appreciated. Cross-posted in "Bioninformatics" since I'm not sure which is the most appropriate forum.
  • bstamps
    Member
    • Oct 2012
    • 40

    #2
    1) If this is a single MiSeq run, and the entire run was devoted to 16s, expect to use at or greater than 32GB of RAM. Our collaborators attempted to do this on the QIIME virtualbox, and had it crash until they fed it more than 20GB of memory. If you don't mind it, try using the AMI that QIIME has on Amazon EC2, or your local cluster (YMMV on that one, it's been hell getting it setup on ours)
    2)The longest/most memory intensive steps are initial clustering (split_libraries_fastq.py) and OTU picking- on the QIIME website they suggest subsampled OTU picking with these types of datasets. I usually do it with the SILVA dataset in a non-subsampled method, but I have lots of memory. Everything else will take you 45 minutes to an hour to complete. That's the fun bit with QIIME.
    3) Stumbling blocks? I'd say the lack of UNIX command line experience, lack of understanding of some of the metrics, and not enough patience when an error gets kicked up.

    As an aside I'd question why you only ran 6 samples- we typically run >96 on each run, with the amplicon receiving "only" 40-50 percent of the run, which still gives us 50-70,000 reads per library. Illumina has given us the ability to overkill our samples, so we try to knock it down to something reasonable (We notice rarefaction curves leveling off pretty fast even at this depth). The "rare biosphere" turned out to mostly be sequencing artefact, so from my end I'd say careful chasing ghosts if you are trying to call something from the QIIME data beyond OTUs that represent < 5% of your libraries.

    Comment

    • danwiththeplan
      Member
      • Sep 2011
      • 72

      #3
      Thanks, very very useful answer

      I'm not running 6 samples, that was just a simple example. I'm advising others on a run that hasn't been done yet, it will be a single MiSeq run multiplexed to ~90 samples, with at least 50% PhiX spikes, probably more like 60%. I did rough calculations on the expected number of sequences that we'd get, they correspond with your results (which is good to know). We will also have to use subsampled OTU picking (or at least de novo OTU picking of some kind) since it's not a well studied biome.
      Sounds like running it on a desktop is going to be a problem due to memory. Our cluster might just handle it, but only just. Good to catch this problem now. Is there any way you could send me a private message with the email of the collaborator you mentioned, could I contact them?
      Last edited by danwiththeplan; 03-26-2013, 07:48 PM. Reason: clarity

      Comment

      • RCJK
        Senior Member
        • May 2009
        • 156

        #4
        Just an fyi, with the new MiSeq software out this week they claim you can get away with only a 5% PhiX spike-in for low diversity libraries.

        Comment

        • danwiththeplan
          Member
          • Sep 2011
          • 72

          #5
          Originally posted by RCJK View Post
          Just an fyi, with the new MiSeq software out this week they claim you can get away with only a 5% PhiX spike-in for low diversity libraries.
          Yes, the reps have been making that claim, new software that picks the clusters more accurately.. it sounds good but I'll let someone else test it

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          18 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          33 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-09-2026, 10:04 AM
          0 responses
          44 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-08-2026, 10:08 AM
          0 responses
          30 views
          0 reactions
          Last Post SEQadmin2  
          Working...